Natixis Elevance Health, Inc. Transaction History
Natixis
- $20.7 Billion
- Q3 2025
A detailed history of Natixis transactions in Elevance Health, Inc. stock. As of the latest transaction made, Natixis holds 301,436 shares of ELV stock, worth $98.2 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
301,436
Previous 41,107
633.3%
Holding current value
$98.2 Million
Previous $16 Million
509.21%
% of portfolio
0.47%
Previous 0.07%
Shares
33 transactions
Others Institutions Holding ELV
# of Institutions
1,779Shares Held
199MCall Options Held
2.38MPut Options Held
2.17M-
Vanguard Group Inc Valley Forge, PA23MShares$7.49 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY20.7MShares$6.75 Billion0.26% of portfolio
-
State Street Corp Boston, MA10.3MShares$3.37 Billion0.12% of portfolio
-
Wellington Management Group LLP Boston, MA6.62MShares$2.16 Billion0.39% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.84MShares$1.9 Billion0.2% of portfolio
About Elevance Health, Inc.
- Ticker ELV
- Exchange NYSE
- Sector Healthcare
- Industry Healthcare Plans
- Shares Outstandng 240,000,992
- Market Cap $78.2B
- Description
- Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....